CGEM – cullinan therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cullinan Therapeutics (CGEM) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Cullinan Therapeutics (CGEM) had its price target raised by Wedbush from $34.00 to $36.00. They now have an "outperform" rating on the stock.
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Cullinan Therapeutics (NASDAQ:CGEM) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Form S-8 Cullinan Therapeutics,
Form 10-K Cullinan Therapeutics, For: Dec 31
Form 8-K Cullinan Therapeutics, For: Mar 10
Form 4 Cullinan Therapeutics, For: Mar 05 Filed by: Michaelson Jennifer
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.